Concepedia

Mark Erikson

ME

Statistics

Publications

11

Citations

1.3K

H-Index

11

Active since

1993

Affiliations

SynZyme Technologies (United States)(Current)

University of California, Los Angeles

Wayne State University

Duke University

Mark Erikson is an author at SynZyme Technologies (United States) specializing in medicine, life sciences, and immunology.

Publications per year

1993–2013

11

Publications

11

Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

Elaine Unemori, L Pickford, Adam Salles et al. · Journal of Clinical Investigation · 1996 · 341 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Recombinant Human Relaxin in the Treatment of Scleroderma

James R. Seibold, Joseph H. Korn, Robert W. Simms et al. · Annals of Internal Medicine · 2000 · 266 citations

Medicine, Dermatology, Pharmacotherapy +6

Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes

Phillip C. Greig, J.M. Ernest, Lisa A. Teot et al. · American Journal of Obstetrics and Gynecology · 1993 · 146 citations

Medicine, Immunology, Obstetrics +12

Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites

Elaine Unemori, Martyn Lewis, James S. Constant et al. · Wound Repair and Regeneration · 2000 · 145 citations

Veterinary Medicine, Bioengineering, Inflammation +12

Relaxin activates the MAP kinase pathway in human endometrial stromal cells

Qiang Zhang, Shu‐Hui Liu, Mark Erikson et al. · Journal of Cellular Biochemistry · 2002 · 83 citations

Life Sciences, Biochemistry, Molecular Biology +13

1–5 of 11